Advertisement

Topics

Ironshore Pharmaceuticals Receives FDA Approval Of Jornay PM For The Treatment Of ADHD

04:00 EDT 10 Aug 2018 | Drug Discovery Development

Jorney PM is a novel formulation of methylphenidate which is taken in the evening and has demonstrated improvement in the severity of ADHD symptoms in the early morning and throughout the day.
Contributed Author: 
Ironshore Pharmaceuticals & Development, Inc.
Topics: 

Original Article: Ironshore Pharmaceuticals Receives FDA Approval Of Jornay PM For The Treatment Of ADHD

NEXT ARTICLE

More From BioPortfolio on "Ironshore Pharmaceuticals Receives FDA Approval Of Jornay PM For The Treatment Of ADHD"

Advertisement
Quick Search
Advertisement
Advertisement